Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- 1 November 2008
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 64 (10) , 850-855
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodiesJournal of Neural Transmission, 2006
- Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease DementiaDementia and Geriatric Cognitive Disorders, 2006
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 2006
- Interface between tauopathies and synucleinopathies: A tale of two proteinsAnnals of Neurology, 2006
- Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markersMechanisms of Ageing and Development, 2006
- Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?Journal of Geriatric Psychiatry and Neurology, 2004
- Core biological marker candidates of Alzheimer?s disease ? perspectives for diagnosis, prediction of outcome and reflection of biological activityJournal of Neural Transmission, 2004
- Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's diseaseMovement Disorders, 2002
- The Neuropsychiatric InventoryNeurology, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984